Adrian RubsteinWhen CRISPR meets Dark Genome: Epigenetic EditingInnovation happens fast in the Biotech industry and the technologies are being superseded a new technology even faster than before. When we…Jul 31, 2023Jul 31, 2023
Adrian RubsteinHarnessing the Benefits of AI for Cell ReprogrammingHuman cell, tissue, or organ transplantation saves many lives and restores vital functions when no other options are available.Jul 31, 2023Jul 31, 2023
Adrian RubsteinHarnessing the Power of the Brain in InvestingInvesting can be a complex and challenging task that requires a great deal of knowledge, expertise, and intuition. However, what many…Feb 17, 2023Feb 17, 2023
Adrian RubsteinThe Game of InvestmentUnderstanding human relations is complex, and no mathematical model can fully explain how and why we make decisions. Nevertheless, in some…Feb 12, 2023Feb 12, 2023
Adrian RubsteinUncertainty and Investing: Exploring the Ellsberg ParadoxOne of the biggest talking points right now is the kind of economic recovery we might see, once the volatility abates. But before we talk…Feb 12, 2023Feb 12, 2023
Adrian RubsteinBig Money in Biotech: Private Equity Firms Betting BigPrivate equity firms have been increasingly investing in biotechnology companies and funds in recent years, as they see the potential for…Feb 2, 2023Feb 2, 2023
Adrian RubsteinInvesting in Molecular Farming: A Growing OpportunityMolecular farming is a form of biotechnology that involves the production of pharmaceutical proteins, industrial enzymes, and other…Feb 1, 2023Feb 1, 2023
Adrian RubsteinHow New Platforms Are Shaping the Future of Preclinical ResearchSince Congress has passed the FDA Modernization Act as part of the FY2023 Omnibus Appropriations Bill to be signed into law by President…Jan 31, 2023Jan 31, 2023
Adrian RubsteinInnovation and the golden circleDear reader, if you want to learn how to apply innovation or how to do innovation, this is not the right read for you. If you want to…Dec 5, 2019Dec 5, 2019
